16 / 64
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 4, July/August 2019
202
AFRICA
CRUDASE scores were useful in stable coronary artery disease
patients who underwent elective coronary angiography. However,
in these patients without ACS, we found that it would be more
appropriate to use the HAS-BLED scoring, which is more
practical, easy to calculate, easy to implement in clinical practice
and more predictive for in-hospital bleeding. Although this study
introduces a new approach, there is a need for larger studies to
make a definite decision in this regard.
References
1.
Rao SV, O’Grady K, Pieper KS,
et al
. Impact of bleeding severity on
clinical outcomes among patients with acute coronary syndromes
. Am J
Cardiol
2005;
96
: 1200–1206.
2.
Mauri L, Kereiakes DJ, Yeh RW,
et al
. Twelve or 30 months of dual
antiplatelet therapy after drug‐eluting stents.
N Engl J Med
2014;
371
:
2155–2166.
3.
Braunwald E, Antman EM, Beasley JW,
et al.
ACC/AHA 2002
guideline update for the management of patients with unstable angina
and non-ST-segment elevation myocardial infarction: a report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Committee on Management of Patients
with Unstable Angina). 2002. Available at
http://www.acc.org/clinical/guidelines/unstable/unstable.pdf. Accessed Aug 19, 2007.
4.
Zhu W, He W, Guo L,
et al
. The HAS-BLED score for predicting major
bleeding risk in anticoagulated patients with atrial fibrillation: a system-
atic review and meta-analysis.
Clin Cardiol
2015;
38
(9): 555–561.
5.
Hsieh MJ, Lee CH, Chen CC,
et al
. Predictive performance of
HAS-BLED risk score for long-term survival in patients with non-ST
elevated myocardial infarction without atrial fibrillation.
J Cardiol
2017;
69
(1): 136–143.
6.
Hsieh MJ, Wang CC, Chen CC,
et al
. HAS-BLED score predicts risk of
in-hospital major bleeding in patients with acute non-ST segment eleva-
tion myocardial infarction.
Thromb Res
2015;
136
(4): 775–780.
7.
Konishi H, Miyauchi K, Tsuboi S,
et al
. Impact of the HAS-BLED score
on long-term outcomes after percutaneous coronary intervention.
Am J
Cardiol
2015;
116
(4): 527–531.
8.
Vries MJ, van der Meijden PE, Henskens YM,
et al
. Assessment of
bleeding risk in patients with coronary artery disease on dual antiplatelet
therapy. A systematic review.
Thromb Haemost
2016;
115
(1): 7–24.
9.
Mehran R, Pocock S, Nikolsky E,
et al
. Impact of bleeding on mortal-
ity after percutaneous coronary intervention results from a patient-level
pooled analysis of the REPLACE-2 (randomized evaluation of PCI
linking angiomax to reduced clinical events), ACUITY (acute catheteri-
sation and urgent intervention triage strategy), and HORIZONS-AMI
(harmonizing outcomes with revascularisation and stents in acute
myocardial infarction) trials.
J Am Coll Cardiol Cardiovasc Interv
2011;
4
: 654–664.
10. Madhavan MV, Généreux P, Palmerini T. The association between
the extent of coronary artery disease and major bleeding events after
percutaneous coronary intervention: from the ACUITY trial.
J Invasive
Cardiol
2015;
27
(4): 203–211.
11. Abu-Assi E, Gracía-Acuña JM, Ferreira-González I,
et al
. Evaluating the
performance of the Can Rapid Risk Stratification of Unstable Angina
Patients Suppress Adverse Outcomes With Early Implementation of
the ACC/AHA Guidelines (CRUSADE) bleeding score in a contempo-
rary Spanish cohort of patients with non-ST-segment elevation acute
myocardial infarction.
Circulation
2010;
121
(22): 2419–2426.
12. Ndrepepa G, Stephan T, Fiedler KA,
et al
. Procedure-related bleeding
in elective percutaneous coronary interventions.
Eur J Clin Invest
2015;
45
(3): 263–273.
13. Jarrah M, Hammoudeh A, Okkeh O,
et al
. Major bleeding events in
Jordanian patients undergoing percutaneous coronary intervention
(PCI): Incidence, associated factors, impact on prognosis, and predict-
ability of the CRUSADE bleeding risk score. Results from the first
Jordanian PCR (PCR1).
Anatol J Cardiol
2017;
17
(6): 445–451.
14. Liu R, Lyu SZ, Zhao GQ,
et al.
Comparison of the performance of the
CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in
ACS patients undergoing PCI: insights from a cohort of 4939 patients
in China.
J Geriatr Cardiol
2017;
14
(2): 93–99.
15. Bang J, Choi SY, KimMH,
et al
. CRUSADE score is superior to platelet
function testing for prediction of bleeding in patients following coronary
interventions.
EBioMedicine
2017;
21
: 213–217.
16. Cordero A, Rodriguez-Manero M, García-Acuña JM. Additive value of
the CRUSADE score to the GRACE score for mortality risk prediction
in patients with acute coronary syndromes.
Int J Cardiol
2017;
245
: 1–5.
17. Ariza-Solé A, Sánchez-Elvira G, Sánchez-Salado JC,
et al
. CRUSADE
bleeding risk score validation for ST-segment-elevation myocardial
infarction undergoing primary percutaneous coronary intervention.
Thromb Res
2013;
132
(6): 652–658.
18. Kharchenko MS, Erlikh AD, Gratsianski
ĭ
NA. Assessment of the prog-
nostic value of the CRUSADE score in patients with acute coronary
syndromes hospitalized in a noninvasive hospital.
Kardiologiia
2012;
52
(8): 27–32.
19. Costa F, Tijssen JG, Ariotti S,
et al
. Incremental value of the CRUSADE,
ACUITY, and HAS-BLED risk scores for the prediction of hemor-
rhagic events after coronary stent implantation in patients undergoing
long or short duration of dual antiplatelet therapy.
J Am Heart Assoc
2015;
4
(12).
20. Faustino A, Mota P, Silva J,
et al
. Non-ST-elevation acute coro-
nary syndromes in octogenarians: applicability of the GRACE and
CRUSADE scores.
Rev Port Cardiol
2014;
33
(10): 617–627.
21. Correia LC, Ferreira F, Kalil F,
et al
. Comparison of ACUITY and
CRUSADE scores in predicting major bleeding during acute coronary
syndrome.
Arq Bras Cardiol
2015;
105
(1): 20–27.